Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Sep 18, 2021 8:22pm
135 Views
Post# 33883870

RE:RE:RE:RE:RE:RE:RE:RE:For anyone new here

RE:RE:RE:RE:RE:RE:RE:RE:For anyone new hereMost of you look at the upside which is all fine and dandy and everyone gets mad when I bring up the downside.  

What happens if covid revenues at 400K again for Q3 or less and they do 20 aristotle tests for Q3 because they "held off with that" so the two companies could be combined and have combined revenue.  You all saw how much cash they burned through in Q2.  They will burn through the same if not more in Q3.  As a company they cant wait until they are out of cash to go back for more.  There is no way they arent working on a deal already to float more shares or to do something.

They wanted the 2:1 RS now so they could push the stock back up to 80 cents and then do another run of investment near that amount.  Then it would had set another base level there. They dont care that all your shares were decreased by 50% all they care about is having enough cash to keep going and keep paying themselves.  sure it woudl had gone lower but all the pumpers here would then be saying so and so invested in at 80 cents and they must know something they are so smart just like the previous investors that are deep in the red now.  Now that is impossible for them to do.  Float shares at this price now and instantly this will be down 10-15 cents a share.  So did I sell at the bottom or did I just finally take all that I can take.

everyone has their breaking point.  to be honest i hope it goes up for. you all.  I just dont see how it will
<< Previous
Bullboard Posts
Next >>